Cough
📧 Sign up to get email alerts when something new happens for Cough.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis [Phase 3]
Phase 3 study evaluating efficacy and safety of HOB-048 CR tablets versus HOB-048 syrup for cough associated with acute or chronic bronchiti…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms.
-
FDA approval · 2018-07-11FDA Approved: MUCUS RELIEF EXTENDED RELEASE — Original Application (Care One (American Sales Company))
FDA approved the original application for MUCUS RELIEF EXTENDED RELEASE (guaifenesin) from Care One (American Sales Company).
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of PEACe containing Ivy, Thyme and Cisti Extract (Phytus) for acute cough and associat…
-
FDA approval · 2018-06-28FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone bitartrate and homatropine methylbromide, maintaining its appro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-06-28FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Novel Laboratories, Inc.)
FDA approved a supplemental application for Hydrocodone bitartrate and homatropine methylbromide from Novel Laboratories, Inc.
-
CLINICAL_TRIALS research · 2018-06-26Clinical Trial Update: Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
The trial investigating exhaled breath condensate pH in patients with cough caused by gastroesophageal reflux has been terminated.
-
FDA approval · 2018-06-08FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Bronchodilating and Bronchoprotective Effects of Deep Inspirations [NA]
A completed clinical trial studied the bronchodilating and bronchoprotective effects of deep inspirations in conditions including asthma and…
-
FDA approval · 2018-03-05FDA Approved: MUCUS DM — Original Application (HyVee Inc)
FDA approved HyVee Inc's MUCUS DM as an original-application generic product containing dextromethorphan hydrobromide and guaifenesin for te…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014) [Phase 2]
Phase 2 study assessing the effect of gefapixant (MK-7264/AF-219) on cough reflex sensitivity in healthy participants and individuals with r…
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012) [Phase 2]
A Phase 2 clinical trial evaluating MK-7264-012 in participants with refractory chronic cough has completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep [Phase 1]
Phase 1 clinical trial evaluating the effects of honey and dextromethorphan on nocturnal cough and sleep. The study status is completed.
-
FDA approval · 2017-08-29FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for a generic combination product containing promethazine, phenylephrine, and codeine phosphate manu…
-
FDA approval · 2017-08-07FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Original Application (KVK-Tech, Inc.)
The FDA approved the generic hydrocodone bitartrate and homatropine methylbromide tablet from KVK-Tech, Inc. under an Original Application, …
-
FDA approval · 2017-07-28FDA Approved: DEXTROMETHORPHAN POLISTIREX EXTENDED-RELEASE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's generic dextromethorphan polistirex extended-release for temporary relief of cough due to colds, flu, or other respira…
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. [Phase 1]
A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of GSK2339345 in subjects with cough has completed.
-
FDA approval · 2017-07-13FDA Approved: MUCINEX DM MAXIMUM STRENGTH — Supplemental Application (RB Health (US) LLC)
FDA approved a supplemental application for Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide) by RB Health (US) LL…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of diphenhydramine, pseudoephedrine, and dropropizine for non-productive cough and acute…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects [Phase 1]
This Phase 1 study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2339345 in healthy subjects. The study ha…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Optimal Remifentanil Ce for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation [Phase 4]
This Phase 4 clinical trial update reports completion of a study evaluating remifentanil for preventing severe cough and hyperdynamic respon…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: GSK2339345 Hypertussive Challenge Study [Phase 2]
GlaxoSmithKline's Phase 2 Hypertussive Challenge Study of GSK2339345 for cough has completed and results were posted in April 2017.
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Effect of Oral Procaterol on Postinfectious Persistent Cough [NA]
A clinical trial update about a study evaluating oral procaterol for postinfectious persistent cough; current status is unknown.
-
FDA approval · 2017-03-17FDA Approved: MUCUS RELIEF DM MAXIMUM STRENGTH — Original Application (Better Living Brands LLC)
The FDA approved the original ANDA for MUCUS RELIEF DM MAXIMUM STRENGTH, a combination product of guaifenesin and dextromethorphan hydrobrom…
-
FDA approval · 2017-02-21FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Original Application (KVK-Tech, Inc.)
FDA approved a generic hydrocodone bitartrate and homatropine methylbromide oral solution from KVK-Tech, Inc. for the relief of cough.